Chinese biopharmaceutical company focused on RNA interference (RNAi) therapeutics, developing small interfering RNA (siRNA)-based medicines for diseases with unmet medical needs
Chinese biopharmaceutical company focused on RNA interference (RNAi) therapeutics, developing small interfering RNA (siRNA)-based medicines for diseases with unmet medical needs. The supplied search result only mentions biopharmaceuticals as a broader investment area and does not provide company-specific details, so this enrichment is based on the company’s known core business.